Genesystem

Venture Capital
PORTFOLIO

Industry : 

DNA Analysis facility and biochip

Investment Year : 

2010

Investment Type : 

Early Stage Financing

Genesystem has sold more than 70 units of equipment to the Korean FDA and other primer companies in 2017. They plan to go public via a technical offering in 2019.

Genesystem has developed the Quick and Real-time portable PCR and long time stable bio-chip, from which DNA verification within 20min is possible.

The company won the Presidential patent prize in 2013. Their patents cover the most compact sized optical design, the shortest heating/cooing structure, and the most reliable bio-chip. With such patents, the most compact-sized, quick PCR equipment was developed.

Genesystem has sold more than 70 units of equipment to Korean FDA and other primer companies in 2017. They plan to go public via a technical offering in 2019.